Subscribe to Newsletter

John Chiminski

Chair and CEO, Catalent Pharma Solutions

In the more than 20 years Chiminski has spent at Catalent, he has overseen the company’s strategy to help accelerate the small molecule development process and improve clinical outcomes. He became chief executive officer in 2009.

“We have learned that companies can act quickly in our industry, where timelines have previously been measured in years and decades. From contracts being put in place to secure capacity, from initial discussion to signed agreements in weeks, not months. In one case, we went from tech transfer to a released batch for a high-profile therapeutic in just ten days.

“When faced with the biggest challenge of our lifetime, Catalent partnered with government and industry to develop vaccines that saved lives and allowed people to get their freedom back. Going forward, I would like to see the industry being able to preserve this speed and recreate it outside of a pandemic by ensuring senior leaders are involved in decisions that can accelerate projects and contracts; making decisions quickly that balance risk alongside back up plans (such as building capacity/facilities with the flexibility to adjust designs if necessary); and having open collaborations, with more sharing partnerships and mutual risk taking.

“I think we have also proven that CDMOs are important, and our customers are including us in all manner of initiatives; for example, in COVID-19 response best practice sharing forums. This demonstration of integration and collaboration has helped the industry solve problems and avoid many supply-chain issues, and we will do all we can to continue in this way. Regulators have also been flexible and available, even adopting remote/on site hybrid inspections to support essential products.”

Part of the Power List 2021

Find out more

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products

Go to The Power List 2021

Part of the Power List 2020

The Power List 2020

Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.

Go to The Power List 2020

Part of the Power List 2019

The Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018

Part of the Power List 2017

Our Top 100 into 4 categories

Go to The Power List 2017

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016

Part of the Power List 2015

Who are the most influential medicine makers?

That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2015

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine